Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 5 ASA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104672114A details a green synthesis route for Furosemide intermediates offering high purity and reduced environmental impact for reliable supply chains.
Patent CN102126977A reveals a novel gas-phase catalytic carboxylation method for 5-ASA production, offering superior yield, purity, and environmental compliance for pharmaceutical supply chains.
Patent CN109503511B reveals a novel 2-step synthesis for dasatinib intermediates using PEG 400, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.